NEW YORK (GenomeWeb News) – Privately-held US Genomics has raised $1 million through a sale of equity and debt securities to company executives and directors, and may raise up to $1 million more, according to a filing with the US Securities and Exchange Commission.

The Woburn, Mass.-based firm offers tools used in the extraction of high-grade DNA, tagging, microfluidics, and genomic mapping, for a range of purposes such as diagnostics, biosecurity, and food and drug monitoring.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.